CH533095A - Verfahren zur Herstellung von Androstan-Verbindungen - Google Patents

Verfahren zur Herstellung von Androstan-Verbindungen

Info

Publication number
CH533095A
CH533095A CH955170A CH955170A CH533095A CH 533095 A CH533095 A CH 533095A CH 955170 A CH955170 A CH 955170A CH 955170 A CH955170 A CH 955170A CH 533095 A CH533095 A CH 533095A
Authority
CH
Switzerland
Prior art keywords
production
androstane compounds
androstane
compounds
Prior art date
Application number
CH955170A
Other languages
English (en)
Inventor
Campbell J Allan
Claude Babcock John
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of CH533095A publication Critical patent/CH533095A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
CH955170A 1969-07-29 1970-06-24 Verfahren zur Herstellung von Androstan-Verbindungen CH533095A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84587769A 1969-07-29 1969-07-29

Publications (1)

Publication Number Publication Date
CH533095A true CH533095A (de) 1973-01-31

Family

ID=25296306

Family Applications (1)

Application Number Title Priority Date Filing Date
CH955170A CH533095A (de) 1969-07-29 1970-06-24 Verfahren zur Herstellung von Androstan-Verbindungen

Country Status (8)

Country Link
US (1) US3580937A (de)
BE (1) BE754111A (de)
CH (1) CH533095A (de)
DE (1) DE2035738A1 (de)
FR (1) FR2059572B1 (de)
GB (1) GB1279186A (de)
IL (1) IL34974A (de)
NL (1) NL7009586A (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5714481A (en) * 1983-08-02 1998-02-03 Research Corporation Technologies, Inc. Derivatives of 5-androsten-17 ones and 5-androstan-17-ones
DE3485647D1 (de) * 1983-08-02 1992-05-21 Research Corp Steroide und diese enthaltende therapeutische zusammensetzungen.
US5804576A (en) * 1983-08-02 1998-09-08 Research Corporation Technologies, Inc. Derivatives of 5-androsten-17-ones and 5-androstan-17-ones
US5656621A (en) * 1983-08-02 1997-08-12 Research Corporation Tech., Inc. Steroids useful as anti-cancer and anti-obesity agents
US5175154A (en) * 1987-11-25 1992-12-29 Research Corporation Technologies, Inc. 5 α-pregnan-20-ones and 5-pregnen-20-ones and related compounds
US5028631A (en) * 1987-11-25 1991-07-02 Schwartz Arthur G Homoandrostan-17-one and homoandrosten-17-ones
US4898694A (en) * 1987-11-25 1990-02-06 Schwartz Arthur G 17-Hydroxy-steroids
US5001119A (en) * 1987-11-25 1991-03-19 Schwartz Arthur G 16-substituted androstanes and 16-substituted androstenes
DK1955700T3 (da) 1999-09-30 2011-05-23 Harbor Biosciences Inc Terapeutisk behandling af androgenreceptor-betingede lidelser
ES2738526T3 (es) 2011-10-14 2020-01-23 Sage Therapeutics Inc Compuestos 19-norpregnano 3,3-disustituidos, composiciones y usos de los mismos
NZ773177A (en) 2012-01-23 2022-09-30 Sage Therapeutics Inc Neuroactive steroid formulations and methods of treating cns disorders
IL275725B (en) 2012-08-21 2022-08-01 Sage Therapeutics Inc Treatment methods for epilepsy and status epilepticus
AU2014256229B2 (en) 2013-04-17 2018-10-04 Sage Therapeutics, Inc. 19-nor C3,3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof
US9725481B2 (en) 2013-04-17 2017-08-08 Sage Therapeutics, Inc. 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
RS60420B1 (sr) * 2013-04-17 2020-07-31 Sage Therapeutics Inc 19-nor neuroaktivni steroidi za metode lečenja
WO2014169836A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
PL3021852T3 (pl) 2013-07-19 2021-07-05 Sage Therapeutics, Inc. Neuroaktywne steroidy, kompozycje i ich zastosowania
JP6466942B2 (ja) 2013-08-23 2019-02-06 セージ セラピューティクス， インコーポレイテッド 向神経活性ステロイド、組成物、及びその使用
US10246482B2 (en) 2014-06-18 2019-04-02 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
JOP20200195A1 (ar) 2014-09-08 2017-06-16 Sage Therapeutics Inc سترويدات وتركيبات نشطة عصبياً، واستخداماتها
HUE051488T2 (hu) 2014-10-16 2021-03-01 Sage Therapeutics Inc Készítmények és eljárások központi idegrendszeri rendellenességek kezelésére
WO2016061527A1 (en) 2014-10-16 2016-04-21 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
US10774108B2 (en) 2014-11-27 2020-09-15 Sage Therapeutics, Inc. Compositions and methods for treating CNS disorders
PL3250210T3 (pl) 2015-01-26 2021-07-26 Sage Therapeutics, Inc. Kompozycje i sposoby leczenia zaburzeń OUN
JP6875996B2 (ja) 2015-02-20 2021-05-26 セージ セラピューティクス， インコーポレイテッド 神経刺激性ステロイド、組成物、およびその使用
WO2017156103A1 (en) 2016-03-08 2017-09-14 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
JP7049313B2 (ja) 2016-07-11 2022-04-06 セージ セラピューティクス， インコーポレイテッド Ｃ１７、ｃ２０、およびｃ２１置換神経刺激性ステロイドおよびそれらの使用方法
ES2992037T3 (es) 2016-07-11 2024-12-05 Sage Therapeutics Inc Esteroides neuroactivos sustituidos en C7, C12 y C16 y sus procedimientos de utilización
CR20240234A (es) 2019-05-31 2024-07-09 Sage Therapeutics Inc ESTEROIDES NEUROACTIVOS Y COMPOSICIONES DE ESTOS (Divisional 2021-629)

Also Published As

Publication number Publication date
IL34974A (en) 1974-06-30
FR2059572A1 (de) 1971-06-04
FR2059572B1 (de) 1974-08-23
BE754111A (fr) 1971-01-29
NL7009586A (de) 1971-02-02
IL34974A0 (en) 1970-09-17
US3580937A (en) 1971-05-25
DE2035738A1 (de) 1971-02-11
GB1279186A (en) 1972-06-28

Similar Documents

Publication Publication Date Title
CH533095A (de) Verfahren zur Herstellung von Androstan-Verbindungen
CH544093A (de) Verfahren zur Herstellung von O-Acyl-lysergolen
AT291933B (de) Verfahren zur Herstellung von Magnesium-Alkohol-Verbindungen
AT305417B (de) Verfahren zur Herstellung von Schaltkreisen
AT295743B (de) Verfahren zur Herstellung von Bleomycinen
CH543553A (de) Verfahren zur Herstellung von Poly-amid-imid-estern
AT299141B (de) Verfahren zur Herstellung von 2-Äthylhexanol
AT306715B (de) Verfahren zur Herstellung von ω-Lactamen
AT308075B (de) Verfahren zur Herstellung von Monochlorbenzaldehyden
AT313878B (de) Verfahren zur Herstellung von Alkylophenolen
AT300840B (de) Verfahren zur Herstellung von Organo-H-silanen
CH543487A (de) Verfahren zur Herstellung von Adamantylharnstoffen
CH544808A (de) Verfahren zur Herstellung von Negamycin
AT310769B (de) Verfahren zur Herstellung von ɛ-Caprolacton
AT324546B (de) Verfahren zur herstellung von aminopenicillinen
AT307418B (de) Verfahren zur Herstellung von neuem 8-Cyano-5-octanolid
CH544758A (de) Verfahren zur Herstellung von Lysergolen
CH497425A (de) Verfahren zur Herstellung von B-Picolin
CH504530A (de) Verfahren zur Herstellung von Cytidin-diphosphat-cholin
AT298431B (de) Verfahren zur Herstellung von Isopren
AT303377B (de) Verfahren zur Herstellung von Polyolefinen
AT301769B (de) Verfahren zur Herstellung von neuen 21-Halogensteroiden
AT314096B (de) Verfahren zur Herstellung von substituierten Cobamiden
CH523774A (de) Verfahren zur Herstellung von Pressteilen
AT303960B (de) Verfahren zur herstellung von alpha-aminobenzylpenicillin

Legal Events

Date Code Title Description
PL Patent ceased